Mitapivat + Sensitive Cyp3a Substrates With Narrow Therapeutic Index Interaction

Contraindicatedinteraction on record

Description

PYRUKYND induces CYP3A, decreasing concentrations of sensitive substrates with narrow therapeutic index. Avoid concomitant use.

Mechanism

CYP3A induction

Source: NLP:mitapivat

Related drug profiles

All Mitapivat interactions →All Sensitive Cyp3a Substrates With Narrow Therapeutic Index interactions →
Share this page:XFacebookWhatsAppReddit